Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease ...
The study demonstrated that asthma treatment is safe, with no significant side effects compared to past studies of the drug.
Benralizabam, a monoclonal antibody, did a better job than steroids at reducing respiratory symptoms like coughing, wheezing, ...
Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung ...
Benralizumab, a monoclonal antibody, is the first breakthrough in asthma and COPD flare-up treatment in 50 years. Targeting ...
It is already used as a recurring treatment for severe asthma in low doses. However, the trial found that a single higher ...
News Medical on MSN3d
New injection treatment could be a game-changer for people with asthma and COPDAn injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, ...
A new study suggests that nicotinamide riboside (a form of vitamin B3) may reduce lung inflammation in COPD patients, with ...
DPA International on MSN1d
UK scientists tout first new asthma attack treatment in over 50 yearsKing's College London (KCL) has announced the development of a "game-changer" injection it says is the first new treatment ...
A new study shows that a form of vitamin B3 can reduce lung inflammation in COPD patients. The researchers hope it will pave the way for new treatment options.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback